Did you guys see the Reuters headline? It says: "Ariad-Merck cancer drug shows mixed results". When you click the story it says: "Ariad/Merck cancer drug impresses in study" Did I miss something here? Where are the results mixed? We are talking about people with life ending cancer here. I just don't get it.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.